A recent report published by Infinium Global Research on acne drugs market provides an in-depth analysis of segments and sub-segments in global as well as regional acne drugs market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional acne drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global acne drugs market. According to the report the global acne drugs market is projected to grow at a CAGR of 4.4% over the forecast period of 2018-2024.
Acne is caused due to excess oil produced by glands on skin and leaves mark or scar on the surface of the skin. Face, neck, shoulder, and chest are the place where acne usually appears. It is an inflammatory and chronic skin disease. Whiteheads, pimples, blackheads, cysts, and nodules are the result of acne. Intensification in androgen level during puberty causes acne. The cellular wall breaks, due to growth in oil glands under the skin that leads to acne. Lack of sleep, smoking, drug misuse, emotional and work-related stress, and alcohol consumption are major activates that causes acne. among teenagers and adults. Acne treatment depends on the skin type and the seriousness of the condition. A permanent cure to the acne problems is offered by Laser treatment that prevents future pigmentation issues.
Increasing consciousness of acne problems among the individual and awareness of the current and upcoming treatments is expected to drive the growth of the market. The growing demand for cosmetic and change in lifestyles is likely to boost the growth in the market. In addition, an increase in per capita has encouraged customers to spend more on personal care. On the other hand, lack of expertise and skilled dermatologist are likely to restrain the growth of the market. Moreover, the availability of drugs without a prescription and the preference for alternative therapies for treating acne has been restricting the sales of branded acne products. Furthermore, technology advancement and research conducted by pharmaceutical companies are likely to bring opportunities to this market. Moreover, the high dispersion of pharmaceutical and biotech companies in emerging regions such as LAMEA and Asia-Pacific bring growth opportunities in this market.
Among the regions, North America is expected to have the largest market share for acne market followed by Europe over the forecast period. Change in lifestyle, increase in awareness about acne problem, and availability of acne treatment options are likely to boost the growth of acne drugs market in this region. Moreover, Asia-Pacific is the fastest growing region owing to the growth in the end-user industry in China and India is likely to augment the market.
The report on global acne drugs market covers segments such as type, route of administration and drug class. On the basis of type the global acne drugs market is categorized into OTC and prescription. On the basis of route of administration the global acne drugs market is categorized into oral and topical. On the basis of drug class, the global acne drugs market is categorized into antimicrobial, combination medications, antibiotics, anti-inflammatory drugs, hormonal agents, topical retinoid and oral retinoid.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global acne drugs market such as Bayer HealthCare, Johnson & Johnson, Anterios, AndroScience, Reckitt Benckiser, Oculus Innovative Sciences, Aqua Pharmaceuticals, Skinvisible Pharmaceuticals, Cipher Pharmaceuticals, and GlaxoSmithKline.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global acne drugs market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of acne drugs market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the acne drugs market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the acne drugs market to understand the present and future trends in this market and formulate their strategies accordingly.